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Abstract 
Objective: This study aims at determining the efficacy of the new 
therapy approach Brainspotting (BSP) in comparison to the established 
Eye Movement Desensitization and Reprocessing (EMDR) approach for 
the treatment of Posttraumatic Stress Disorder (PTSD). Method: The 
sample consisted of 76 adults seeking professional help after they have 
been affected by a traumatic event. Clients were either treated with three 
60-minute sessions of EMDR (n=23) or BSP (n=53) according to a 
standard protocol. Primary outcomes assessed were self-reports of the 
severity of PTSD symptoms. Secondary outcomes included self-
reported symptoms of depression and anxiety. Assessments were 
conducted at pretreatment, posttreatment and 6 month after the 
treatment. Results: Participants in both conditions showed significant 
reductions in PTSD symptoms. Effect sizes (Cohen’s d) from baseline 
to posttreatment concerning PTSD related symptoms were between 1.19 
- 1.76 for clients treated with EMDR and 0.74 - 1.04 for clients treated 
with BSP. Conclusion: Our results indicate that Brainspotting seems to 
be an effective alternative therapeutic approach for clients who 
experienced a traumatic event and/or with PTSD. 
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Introduction 
Posttraumatic Stress Disorder (PTSD) is defined as “a delayed or 
protracted response to a stressful event or situation (of either brief or 
long duration) of an exceptionally threatening or catastrophic nature, 
which is likely to cause pervasive distress in almost anyone” (World 
Health Organization, 1992, p. 147). In general, the range for lifetime 
PTSD lies between a low of 0.3% in China to 6.1% in New Zealand 
(Kessler & Üstün, 2008). Current past year PTSD prevalence was 
estimated at 3.5% (Kessler, Chiu, Demler, Merikangas, & Walters, 
2005), with 1.8% among men and 5.2% among women (National 
Comorbidity Survey, 2005). The prevalence of full or partial PTSD in 
the primary care medical setting is reported with 12% of the primary 
care attendees (Stein, McQuaid, Pedrelli, Lenox, & McCahill, 2000). 
The presence of PTSD is positively correlated with higher levels of 
health-related problems (Schnurr & Green, 2004) and lower levels of 
functioning (Thorp & Stein, 2005). Moreover, PTSD is often a 
persistent and chronic disorder (Perkonigg et al., 2005). Thus, effective 
treatments for PTSD are needed.  
There are different treatment approaches to reduce the symptoms of 
PTSD. Some already existing approaches were specially modified for 
the treatment of traumatic experiences, e.g., trauma-focused cognitive-
behavioral therapy (Benkert, Hautzinger, & Graf-Morgenstern, 2008). 
Others are developed primarily for the treatment of PTSD, e.g., Eye 
Movement Desensitization and Reprocessing (EMDR, Shapiro, 2001), 
Narrative Exposure Therapy (NET, Schauer, Neuner, & Elbert, 2011) or 
Brainspotting (BSP, Grand, 2013).  
In an early meta-analysis by van Etten and Taylor (1998), the most 
effective drug therapies as well as the best psychological therapies, 
namely EMDR and behavior therapy, were found equally effective. 
Later, at least four other meta-analyses confirmed that EMDR is 
empirically proven to be the best treatment for PTSD in addition to the 
cognitive-behavioral therapies (Bisson & Andrew, 2007; Bisson, 
Roberts, Andrew, Cooper, & Lewis, 2013; Bradley, Greene, Russ, 
Dutra, & Westen, 2005; Maxfield & Hyer, 2002; Seidler & Wagner, 
2006). 
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Primary aims of the present study were to compare the efficacy of Brainspotting 
with the established EMDR-therapy and to detect areas of significant 
change or lack of change (program evaluation). Outcomes assessed 
were the severity of PTSD symptoms as well as the symptoms of 
depression and anxiety. 
 
Methods 
Design and Sample 
The data for this multicenter longitudinal study were collected by 
independent psychotherapists in Germany, the United States of 
America, Austria, Switzerland and Italy. The therapists were previously 
informed about the study by mail or during EMDR and BSP trainings. If 
the therapists were interested in participating, they were instructed by 
mail and/or phone and then received a package with all study material.  
The treatment and data collection was carried out by 27 experienced 
trauma therapists. There was a pre-determined standard protocol for 
both EMDR and BSP, which the therapists had to follow during their 
treatment. Therapists were licensed therapists who were fully educated 
in EMDR through an accredited training facility and they had at least 
completed the Phase I training in Brainspotting. Thus, clients were able 
to choose whether they would be treated with the established therapy 
approach EMDR or the new therapy approach BSP. In case the client 
chose BSP and the therapy outcome was not satisfactory, he/she had the 
right to receive additional EMDR sessions. None of the clients have 
taken up this offer. 
Data was collected before the first therapy session, after one week after 
the third therapy session and after about half a year (M=6 month; range: 
2-12 month, with 69% were conducted after 5, 6 or 7 month). The 
sample is composed of 76 consecutive clients (79% female; mean age 
42.0 years) starting their therapy between 2009 and 2015. The inclusion 
criteria were: a) adult clients aged 18 and over; b) the client have either 
experienced a traumatic situation and / or suffer from a posttraumatic 
stress disorder or acute stress disorder; and c) the client gives his written 
consent to participate in the study. The client was deemed not eligible 
for the study when the treatment already included more than the 
preparatory sessions. Between the posttest and the follow-up assessment 
no treatment of the trauma under focus was applied. Only counseling or 
supportive sessions were possible and if needed another trauma might 
be treated. Finally we collected data of 53 clients treated with BSP and 
23 clients treated with EMDR. The study was reviewed and approved 
by an ethics committee of the University of Bielefeld. Informed consent 
was obtained from all research participants being involved in this 
research after the study and the procedures were explained. 
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Treatment 
The Therapy Approach Eye Movement Desensitization and 
Reprocessing (EMDR). EMDR was developed by Francine Shapiro 
(2001). It is a well-established therapy for the treatment of PTSD or 
other trauma associated diseases. EMDR consists of eight phases, from 
which phases three to six are original EMDR stages. After establishing a 
good therapist-client relationship and after the introduction of relaxation 
techniques or other stabilization techniques, the client is asked to re-
experience the traumatic situation while focusing on the therapist’s 
finger tips which are moving on a horizontal axis in front of his or her 
eyes. In a safe environment and as part of a good therapeutic 
relationship, the client relives the traumatic situation and reprocesses the 
feelings, emotions, cognitions and body sensations connected to the 
trauma (Schubbe, 2006).  
The Therapy Approach Brainspotting (BSP). BSP is a 
psychotherapeutic model discovered in 2003 by David Grand, Ph.D.. 
Grand has conceptualized BSP as brain-wise and body-aware relational 
attunement process. In this context he has developed the model of the 
Dual Attunement Frame. The foundation of this model is the 
articulation of the attuned, relational presence of the therapist with the 
client. This relational attunement is seen as being both focused and 
deepened by the neurological attunement derived from observing and 
harnessing different aspects of the visual orienting reflexes of the client 
(Corrigan & Grand, 2013). 
By slow eye tracking, either with one eye or with two eyes, locations for 
BSP are identified. To find these locations, the techniques of either 
“Inside Window“ or “Outside Window” can be used. The “Inside 
Window” utilizes the client’s felt sense, the “Outside Window” helps to 
locate this location by observation of clients’ reflexive response such as 
blinks, eye twitches or wobbles or quick inhalation, by the therapist.  
Once the therapist and client determine together the Brainspot, the client 
is directed to maintain their fixed visual attention on the position and 
mindfully observe their internal process. In BSP this is called Focused 
Mindfulness as the mindfulness that ensues occurs in a state of Focused 
Activation. The Focused Mindfulness ensues, with the therapist closely 
and openly following along until the client comes to a state of 
resolution. 
BSP is a focused treatment method that works by identifying, 
processing and releasing core neurophysiological sources of 
emotional/body pain, trauma, dissociation and a variety of other 
challenging symptoms (Grand, 2011). In BSP, the therapist is 
encouraged to openly follow the client’s process with no assumptions. 
The therapist is guided to trust the innate human neurological capacity 
for self-regulation given optimal conditions. In this context, the BSP 
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therapist also guides the client to become brain-aware through ongoing 
opportunities for psycho-education. For a more detailed description of 
BSP, the reader may consult Grand (2013). The standardized protocol 
determines the usage of “two eyes” and the “Inside Window”. 
First results indicate that Brainspotting could be an effective therapy 
approach for the treatment of clients having experienced traumatic 
experiences and clients with generalized anxiety disorder (Anderegg, 
2016; Hildebrand, Stemmler, & Grand, 2015; NSHCF, 2016). 
 
Measures 
PTSD and symptom severity. To screen the clients for the presence of 
PTSD and to assess the symptom severity and functioning of the clients 
the Posttraumatic Diagnostic Scale (PDS; Ehlers, Steil, Winter, & Foa, 
1996; Foa, Cashman, Jaycox, & Perry, 1997) was administered. The 
PDS has 49 items. It includes a 12 item checklist identifying potentially 
traumatizing events experienced by the respondent. Respondents then 
indicate which of these events has troubled them most in the last month. 
To determine whether the DSM-IV stressor criteria are met, the 
response to this event at the time of its occurrence should be rated. 
Clients then rate 17 items representing the cardinal symptoms of PTSD 
experienced in the past 30 days on a four-point scale (0-3). In the last 
part respondents indicate the level of impairment caused by their 
symptoms across nine areas of life functioning. By adding up the scores 
of the corresponding items, the symptom severity for the three subscales 
re-experiencing (5 items), avoidance/numbing (7 items) and 
hyperarousal (5 items) is calculated. The total symptom severity score is 
obtained by adding up the responses of selected items and ranges from 0 
to 51 (1-10 = mild, 1-20 = moderate, 21-35 = moderate to severe, > 36 = 
severe).  
Additional mental impairment. Additional mental impairment was 
investigated through the Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983). This self-rating scale measures 
states of depression and anxiety and features seven questions for anxiety 
(HADS-A) and seven for depression (HADS-D). The respondent rates 
each item on a four-point scale. The scores for the subscales range from 
0 to 21.  
Demographic data. Data included sex, date of birth, marital status, place 
of residence, socioeconomic status (0=low, 1=average, 2=high), 
traumatic experience (item “How would you describe the client’s 
trauma?”) with a five point rating scale with the response categories 
from 1 (minor) to 5 (major) and ICD-10/DSM-IV diagnosis of the 
client. 
 
Data Analysis 
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Analyses were conducted using SPSS 23. Independent samples t-tests and 
χ2-analyses were conducted to determine whether there were  
 
 
statistically significant differences between the means of those treated with 
BSP and those treated with EMDR on the demographic variables. We used 
univariate two factor analysis of variance (ANOVA) with repeated measures 
and χ2-tests to assess treatment effects. Effect sizes were calculated according 
to Cohen’s (1988) d statistic. For each scale of the PDS and HADS and for 
each treatment group the magnitude of change from pre-to posttest, from pre- 
to follow-up and from posttest to follow-up was defined as (M1-
M2)/SDpooled, where SDpooled = [(SD12+SD22)/2]1/2. Positive effect sizes 
represent improvements in PTSD and other symptoms (depression, anxiety). 
Negative effect sizes indicate a worsening of symptoms. The sample sizes for 
the different items vary slightly due to missing data.  
 
 
 
Results 
 
Demographic Data and Traumatic Experiences 
Demographic data. Results of χ2- and t-test analyses comparing those treated 
with BSP and those treated with 
EMDR indicated no statistically significant differences regarding gender, age, 
family status and PTBS diagnosis – 
except place of residence (Table 1).  
 
- Table 1 –  Appendix 1 
 
Traumatic experiences. Both groups of clients most frequently listed as the 
worst traumatic experience an event that is not explicitly mentioned in the PDS 
(EMDR: 48%, BSP: 37%, examples: working with death bodies, psychological 
abuse). Accidents were marked by 17% of the clients treated with EMDR and 
23% treated with BSP. Sexual assault by someone known was listed by 22% of 
the EMDR clients and 18% of the BSP clients. The other traumatic events were 
each marked by less than 10% of the client group. Differences between groups 
concerning the worst traumatic event were not statistically significant (χ2 [9, N = 
75] = 5.11, p = .825). 
 
Outcome Measures 
PDS. Table 2 summarizes the means and standard deviations of the PDS for the 
pretest, posttest and follow-up for both treatment groups. The results of the 
univariate two factor analysis of variance (ANOVA) with repeated measures and 
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the effect sizes are also listed. We found a significant time effect in all four scales of 
the PDS, showing a decrease in the reported symptoms for both treatment  
 
groups. We did not find a significant interaction effect, revealing no significant 
differences between the groups concerning the decrease of symptoms. Pre-follow-
up effect sizes for the measures of PTSD symptoms for both EMDR (d = 1.11 - 
2.12) and BSP treatment (d = 1.06 - 1.36) were high. The same applies to pre-post 
effect sizes for EMDR (d = 1.19 - 1.76) and BSP (d = 0.74 - 1.04). 
 
- Table 2 – Appendix 2 
 
HADS. Results for the HADS are presented in table 3. Clients treated with 
EMDR as well as clients treated with BSP reported a significant decline in 
symptoms of anxiety and depression. The between groups tests indicate that the 
variable treatment group is not significant for both scales. Moreover, the 
interaction of time and group is not significant which means that the groups are 
not changing in different ways over time. 
Pre-follow-up effect sizes for the HADS were high. 
 
- Table 3 – Appendix 3 
 
Discussion 
 
We aimed to investigate a comparison between treatment outcomes in clients 
treated with EMDR and BSP. The latter is a new psychotherapy approach which 
theorizes that the field of vision can be used to locate eye positions that correlate 
with relevance to inner neural and emotional experience (Grand, 2011). With a 
growing recognition of BSP as an alternative treatment approach for PTSD, this 
study helps to support the need for the evaluation of treatment efficacy.  
We found that clients treated with BSP weren‘t more impaired than clients 
treated with EMDR in the variables under consideration. Brainspotting seems to 
be an effective therapeutic approach for clients who experienced a traumatic event 
and/or with PTSD. Additionally, BSP seems to be as effective as EMDR in many 
areas under examination (cardinal symptoms of PTSD, anxiety and depression). 
In this vein, our study supports the results of Sack et al. (2016) who compared 
dual attention, eye movements, and exposure only during EMDR in a randomized 
clinical trial. The use of eye movements as a dual-attention task had no additional 
treatment effects compared to visual fixation on a nonmoving hand. The pre-post 
effect sizes for the EMDR treatment group in our study are comparable to other 
findings (Bradley et al., 2005; Maxfield & Hyer, 2002; van Etten & Taylor, 
1998), where effect sizes for pre- versus post-treatment comparisons range 
between -.50 and 2.22. Even though the pre-post effect sizes for BSP were 
apparently a bit smaller, there was no significant difference between groups 
concerning the treatment outcome in either of the scales. 
                                                                                                      HILDEBRAND, GRAND et al. 8 
Our study had a longitudinal and quasi-experimental design with two 
equivalent comparison groups. According to the Maryland Scientific Method 
Scale (SMS; Sherman et al., 1997), which evaluates the methodological quality of 
studies, our study is positioned at level 3 on a 5-point scale. The authors indicate 
that confidence in the results is highest at level 5 and level 3 is required to achieve 
reasonably accurate results. As differences between groups were analyzed and not 
statistically significant, threats to internal validity were minimized. For example, 
regression towards the mean (Stigler, 1997) could be precluded, as there were no 
group differences for example in the trauma severity score at pretest. 
 
Limitations of the Present Study 
Although improvements in symptoms of PTSD have been observed with BSP, 
we can only state preliminary conclusions on the benefits of this intervention due 
to the relatively small sample size. Thus, more research with larger samples is 
needed to replicate our results. 
Another limitation of this paper is that we did not use a randomized trial. As 
randomized controlled trial is often considered the gold standard in evaluating 
treatment efficacy (Misra, 2012), we also thought about using this design. Due to 
organizational and ethical issues (Edwards et al., 1998; Sullivan, 2011), we 
decided that clients should have the possibility to choose whether they are treated 
with EMDR or BSP.  
Both, EMDR and BSP were successful in treating clients with traumatic 
experiences. Therefore, the common factors in the two treatment approaches and, 
in general, for all effective trauma therapies should be taken into consideration 
(Wampold, 2015). Both treatments start with the anamnesis and therapy planning 
(Schubbe, 2014). In both treatments, the personality and particular attributes of 
the therapist, the therapeutic relationship, the need of establishing personal safety 
and stability, and the reprocessing of the traumatic experience could have for 
example affected treatment outcome. In our study we did not focus on these 
moderators of treatment outcome. In sum, the development of trauma treatment 
methods include more and more resource orientation, and BSP follows this 
overall direction (Schubbe, 2016). 
 
Conclusions and Future Prospects  
To conclude, our study supports the use of BSP to treat subjects who show 
symptoms of PTSD. Thus, BSP seems to be an alternative treatment approach for 
clients with PTSD. More research is needed to replicate our results and to 
evaluate effects in different samples, e.g., clients with substance use disorders and 
comorbid PTSD. Moderator analyses are necessary to further evaluate the 
contribution of BSP to the treatment of PTSD. Further studies should also analyze 
the potential usefulness of BSP with other diagnostic measures like the Clinician-
Administered PTSD Scale for DSM-5 (CAPS-5, Weathers et al., 2013).  
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Appendix 1 
Tab. 1. – Comparisons of Demographic information of treatment groups. 
 
 BSP 
(n = 53) 
EMDR 
(n = 23) 
 
 M or n SD or % M or n SD or % χ2 or t 
Gender (female) 41 77.4 19 82.6 .27 
Age (years) 43.43  
(range: 22-69) 
12.30 38.74  
(range: 19-58) 
12.90 -1.51 
Marital status     7.00 
  Married 19 36.5  26  
  Engaged   1   1.9  0  
  Cohabitating 12 23.1  13  
  Divorced   8 15.4  22  
  Single 12 23.1  30  
  Other   0   0  9  
Place of residence     13.63** 
  Germany 33 62.3 14 60.9  
  USA 20 37.7   4 17.4  
  Austria    0   3 13.0  
  Switzerland    0   1   4.3  
  Italy    0   1   4.3  
Socioeconomic status     0.63 
  Low  26  23  
  Average  65  62  
  High    9  15  
Trauma severity 
score 
  4.78  
(range: 2-5) 
  3.72   4.22  
(range: 2-5) 
  0.85 -0.72 
PTSD diagnosis by 
therapist a 
    .04 
  Simple PTBS 21 42.9 10 45.5  
  Complex PTBS 28 57.1 12 54.5  
PTSD diagnosis by 
PDS (yes) 
29 54.7 15 65.2 .725 
Additional diagnosis 
(yes) 
23 43.4   8 34.8 .49 
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Note. BSP = Brainspotting; EMDR = Eye Movement Desensitization and Reprocessing. aBSP: N=4 
missing, EMDR: N=1 missing. * p < .05. ** p < .01. *** p < .001.   
 
 
Appendix 2  
 
Tab. 2. –  PDS. Univariate two factor analysis of variance (ANOVA) with repeated 
measures and effect sizes 
 
 Pre Post FU ANOVA d 
(EMDR: n=18,  
BSP:  n=42) 
M 
 
SD M 
 
SD M SD time 
F (2, 59) 
η² 
group 
F (1, 60) 
η² 
time*gro
up 
F( 2, 59) 
η² 
dPre-FU dPre-
Post 
dPost
-FU 
Total score       44.16*** 
.60 
.26 
.00 
2.03 
.07 
   
   EMDR  29.4 12.67 10.4 10.42 8.0  6.52    2.12 1,64 0.28 
   BSP  25.9 12.36 14.6 10.59 10.9  
10.59 
1.30 0.98 0.35 
Reexperience       44.08*** 
.60 
1.61 
.03 
1.31 
.04 
   
   EMDR  8.8 4.33 2.4 2.77 1.7  1.81    1.11 1.76 0.30 
   BSP 8.5 4.62 4.3 3.39 3.0  3.35    1.36 1.04 0.39 
Avoidance       37.15*** 
.56 
.11 
.00 
1.64 
.05 
   
   EMDR 11.3 5.48 4.6 5.77 2.6  2.83    1.99 1.19 0.44 
   BSP  9.8 5.69 5.8 5.17 4.0  4.49    1.13 0.74 0.37 
Hyperarousal       31.00*** 
.51 
.04 
.00 
2.72 
.08 
   
   EMDR  9.3 4.28 3.3 3.20 3.7 3.12    1.50 1.59 -
0.12 
   BSP  7.6 3.66 4.5 3.03 3.8  3.54    1.06 0.92 0,21 
Note. PDS = Posttraumatic Diagnostic Scale; pre = pretest, post = posttest, FU = follow-up; 
BSP = Brainspotting; EMDR = Eye Movement Desensitization and Reprocessing. M=mean; 
SD=standard deviation. * p < .05. ** p < .01. *** p < .001. Effect sizes: Cohen (1988): (M1-
M2)/ SDpooled 
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Appendix 3 
Tab. 3. – HADS. Univariate two factor analysis of variance (ANOVA) with 
repeated measures and effect sizes 
 
 Pre Post FU ANOVA                 d 
(EMDR: 
n=18,  
BSP: n=43) 
M 
 
SD M 
 
SD M SD time 
F (2, 58) 
η² 
group 
F (1, 59) 
η² 
time*group 
F( 2, 58) 
η² 
dPre-FU dPre-
Post 
dPost-FU 
Anxiety       44.38*** 
.62 
.13 
.01 
    0.89 
    .02 
   
   EMDR  14.1 4.67 7.1 5.50 6.8 4.93    1.52 1.37 0.06 
   BSP  12.5 3.55 7.0 4.12 6.8  5.03 1.31 1.43 0.04 
Depression       35.83*** 
.55 
.15 
.00 
1.31 
.04 
   
   EMDR  11.1 5.13 5.4 5.68 4.7 5.32    1.22 1.05 0.13 
   BSP 9.5 4.96 5.3 4.79 4.9 4.80    0.94 0.86 0.08 
Note. HADS = Hospital Anxiety and Depression Scale; pre = pretest, post = posttest, FU = follow-up; 
BSP = Brainspotting; EMDR = Eye Movement Desensitization and Reprocessing. M=mean; SD=standard 
deviation. * p < .05. ** p < .01. *** p < .001. Effect sizes: Cohen (1988): (M1-M2)/ SDpooled 
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